Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs

被引:2
|
作者
Piccorelli, Annalisa V. [1 ]
Fraker, Sarah A. [2 ]
机构
[1] Univ Wyoming, Dept Math & Stat, Dept 3036,1000 E Univ Ave, Laramie, WY 82071 USA
[2] HCA Holdings Inc, Clin Serv Grp, Nashville, TN USA
关键词
Birth-and-Death Urn with Immigration; equal allocation; Modified Play-the-Winner; randomized-play-the-winner; response-adaptive randomization; PLAY-WINNER RULE;
D O I
10.1080/10543406.2018.1437172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During a clinical trial, balancing statistical and ethical considerations are important. Response-adaptive randomization methods use the information from past patients to increase the probability of the next patient receiving the better treatment while avoiding the statistical concern of selection bias. We compared three response-adaptive randomization urn designs, Randomized Play-the-Winner, Modified Play-the-Winner, and Birth-and-Death Urn with Immigration, to the traditional equal allocation design with respect to power and allocation of patients to the better treatment. Because these designs have been described separately, our motivation was to systematically compare them and provide recommendations. With simulations, we varied sample size and combinations of treatment and control success probabilities. We also compared the response-adaptive randomization designs using exact distribution algorithms and applied them to past clinical trial data that used an equal allocation design. We conclude that Modified Play-the-Winner tends to be unpredictable and can result in allocation of all of the patients to the better treatment. Randomized Play-the-Winner allocates more patients to the better treatment than Birth-and-Death Urn with Immigration, but Birth-and-Death Urn with Immigration is more consistent in its allocations. Randomized Play-the-Winner and Birth-and-Death Urn with Immigration produce allocations that have comparable powers to equal allocation design.
引用
收藏
页码:1105 / 1118
页数:14
相关论文
共 50 条
  • [31] Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials
    Biswas, Atanu
    Hattacharya, Rahul
    [J]. DRUG INFORMATION JOURNAL, 2010, 44 (01): : 9 - 19
  • [32] Optimal response-adaptive allocation designs in phase III clinical trials: Incorporating ethics in optimality
    Biswas, Atanu
    Bhattacharya, Rahul
    [J]. STATISTICS & PROBABILITY LETTERS, 2011, 81 (08) : 1155 - 1160
  • [33] Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials
    Atonu Biswas
    Rahul Bhattacharya
    [J]. Drug information journal : DIJ / Drug Information Association, 2010, 44 (1): : 9 - 19
  • [34] Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial
    Ghiglietti, Andrea
    Scarale, Maria Giovanna
    Miceli, Rosalba
    Ieva, Francesca
    Mariani, Luigi
    Gavazzi, Cecilia
    Paganoni, Anna Maria
    Edefonti, Valeria
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (06) : 1203 - 1215
  • [35] Comment: Is Response-Adaptive Randomization a "Good Thing" or Not in Clinical Trials? Why We Cannot Take Sides
    Giovagnoli, Alessandra
    [J]. STATISTICAL SCIENCE, 2023, 38 (02) : 224 - 228
  • [36] SEQUENTIAL MONITORING OF RESPONSE-ADAPTIVE RANDOMIZED CLINICAL TRIALS
    Zhu, Hongjian
    Hu, Feifang
    [J]. ANNALS OF STATISTICS, 2010, 38 (04): : 2218 - 2241
  • [37] Comparison of treatments with ordinal responses in trials with sequential monitoring and response-adaptive randomization
    Yu, Yian
    Xu, Cong
    Zhong, Junjiang
    Cheung, Siu Hung
    [J]. STATISTICS IN MEDICINE, 2022, 41 (25) : 5061 - 5083
  • [38] Ethical Considerations in Adaptive Design Clinical Trials
    Thomas Laage
    John W. Loewy
    Sandeep Menon
    Eva R. Miller
    Erik Pulkstenis
    Natalia Kan-Dobrosky
    Christopher Coffey
    [J]. Therapeutic Innovation & Regulatory Science, 2017, 51 : 190 - 199
  • [39] Ethical Considerations in Adaptive Design Clinical Trials
    Laage, Thomas
    Loewy, John W.
    Menon, Sandeep
    Miller, Eva R.
    Pulkstenis, Erik
    Kan-Dobrosky, Natalia
    Coffey, Christopher
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (02) : 190 - 199
  • [40] AN URN MODEL FOR ODDS-RATIO-BASED RESPONSE-ADAPTIVE PHASE III CLINICAL TRIALS FOR TWO OR MORE TREATMENTS
    Basak, Gopal K.
    Biswas, Atanu
    Volkov, Stanislav
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (05) : 838 - 856